Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > What Happens on May 31
View:
Post by Forestview on May 26, 2021 7:34am

What Happens on May 31

This question has been asked, but never answered.  So, on May 31st, do the AH shares get added to the pot overnight, causing a drop in the share price (since Market Cap will be constant).  Or, does the the share price stay constant and the market cap increase?  Or is there a third scenario?  And, if there is a drop in share price, which i think is the more likely scenario, is the drop 11% due to the AH % allocation.
Comment by Forestview on May 26, 2021 7:59am
Actually just heard from Dan.  So, the MC will increase as it absorbs AH.  How the market reacts will drive share price.  Hopefully this is the last hurdle holding this stock down.  
Comment by MikeStock on May 26, 2021 8:12am
Thanks for the clarification. Much appreciated. 
Comment by StockingUp21 on May 26, 2021 8:35am
The only hurdle is guy who you just heard from.   
Comment by GameChangerBet on May 26, 2021 8:49am
Do you have any inventory in your vocabulary other than "dilution" "pumper" "Dan this Dan that" ? This is the only basis of your posts in it's totality. Do you comprehend the stupidity and foolishness of being so negative about an investment or a significant aspect of it to the point where your entire repertoire consists of nothing but negative sentiment but ...more  
Comment by StockingUp21 on May 26, 2021 9:04am
Ok I will blindly defend company. Nothing is wrong it's everyone else fault. How's this?
Comment by MikeStock on May 26, 2021 9:13am
I think the point is to have some balance. I get both sides here so that's not my issue. Someone over at CEO posted Antibe's latest tweet which is a great positioning of the value of our future drug, but then look at the first comment. Some guy bashing the stock price. Now, anyone who comes along and is inspired that ATE is trying to solve this NSAID ulcer issue just sees a basher as the ...more  
Comment by Layth1990 on May 26, 2021 9:22am
I said this before and bashers start crying about their right for speach freedom. i can undertand their frustration from delays and moving slowly but as you said Fud  is just  going to hurt everyone. 
Comment by YukonJezza on May 26, 2021 9:59am
layth you were the biggest basher of them all. I suggest everyone read layths posts from may 6 2021
Comment by Forestview on May 26, 2021 9:26am
Yeah, that first tweet response is certainly a deterent.  Not much to do about it.  
Comment by StockingUp21 on May 26, 2021 9:54am
Maybe takeaway here is optics make or break. Maybe the company can build on this. Give me a reason to believe again. I lost my faith. Been a very bad year.
Comment by GameChangerBet on May 26, 2021 9:22am
As expected, you have missed the point.  The point that was made, was a simple one. There may be things wrong with a company, management might be inadequate, etc. If this is your position, your action to mitigate that concern is to continuously repeat the same, zero value rhetoric about how terrible things are. The point is a very clear one. With any investment, your seeing the actions of ...more  
Comment by 123ABC on May 26, 2021 11:02am
I'll believe it when I see it, all this stock has done is condition me to expect red. It may run a little get everyone excited then BAM, one day -1% the next -2%  maybe a little blip of green the next then another -5% till eventually we're back at $4.00 this stock LOVES $4 At least that's been my experience with this stock and i've been holding for over a year now.
Comment by WalkOverTheStrt on May 27, 2021 4:21pm
Antibe should'nt and I doubt they will be impacted by one off negative tweets, emails and such from retail investors... Shy away, I hope not... This is business... 
Comment by 123ABC on Jun 04, 2021 3:19pm
Looks like MC is decreasing
Comment by Forestview on Jun 04, 2021 3:53pm
The number of shares outstanding is still 45.5million, so Holdings hasn't been included, and therefore the patents' value hasn't been included in the MC either.  
Comment by 123ABC on Jun 07, 2021 10:42am
Looks like MC is still going down
Comment by Forestview on Jun 07, 2021 11:01am
This stock will keep getting pounded down unless there's a news release with $$$ figures in it.  It doesn't matter what they say in a press release.  No dollars?  No movement up.   (and I do think someone is manipulating this stock to stay at these rates).
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities